Surface Hygiene - BodyGuard looking extremely good!

Surface Hygiene
A great deal of activity was directed to the surface hygiene opportunity during the period with further discussions with multiple interested partners, the completion of testing that reconfirmed the bacteria kill rate using BKC on golden staph using OBJ’s technology and the commencement of the first prototype development for the intended first application. This opportunity has gained much traction over the period as it would appear the OBJ approach could be quite significant in dealing with growing resistance to various surface treatments using commonly available disinfectants as advised by potential partnering companies. The results of the recent testing at the University of Western Australia have reinforced the Company’s commitment to investing in hardware development ahead of further meetings with targeted distribution companies.

BodyGuard
Over the period, the Company continued to invest considerable time and expenditure working with its US consultants in refining the complex manufacturing requirements for the first KneeGuard product and the forthcoming “hot dot” general BodyGuard product designs. This work is now particularly directed at the use of the key hydrogel formulation in the BodyGuard manufacturing process which will be an important IP consideration with prospective licensees. Discussions with potential licensees continue as planned, in both Europe and the USA over the July period. Discussions have moved a step closer with two potential Licensees for BodyGuard expressing strong interest in the entire product portfolio. The Board remains very pleased with progress in both the manufacturability of the product range as well as the potential distributor discussions.

Happy to hold
Regards
Combi